Latest News
Study Sheds Light on Pathology of End-Stage Lung Disease in IPF and CF
Pirfenidone-Loaded Nanoparticles as an Alternate Treatment for IPF
Newly Developed Algorithm Differentiates IPF From Other Lung Diseases
Study Identifies Major Suppressor of Fibroblast Activation in IPF
IgG1-Positive Cell Infiltration Prognostically Useful in IPF
Comorbidities in IPF Linked With Poor Survival
FDA Grants TTI-101 Orphan Drug Designation for IPF
Novel 3D Lung Volume CT Useful for Predicting IPF Exacerbations
Revised Definition Affects Reported Rate of Acute Exacerbations in IPF
Latest Clinical Trials
Insights
The Challenges of Using Gene Therapy to Treat Respiratory Disease
Researchers are increasingly exploring the potential of gene therapy in treating respiratory diseases.
The Continuing Evolution of Our Understanding of IPF
Various researchers have chronicled how our understanding of idiopathic pulmonary fibrosis has undergone tremendous changes over the years.
The Role of Visual Analog Scales in Understanding the IPF Patient Experience
Researchers explain why they believe visual analog scales are ideal assessment tools for understanding patients’ experiences.
The Complex Challenge of Treating IPF With Comorbid Pulmonary Hypertension
We explore the vast medical challenge of treating the combination of idiopathic pulmonary fibrosis and pulmonary hypertension successfully.
How Telomere Dysfunction Drives Pathogenesis in IPF
We explore how telomere dysfunction potentially drives the pathogenesis of idiopathic pulmonary fibrosis, and what that could mean for future research.
Understanding the Pathological Processes That Lead to Fibrosis in IPF
We explore the pathological processes that result in the fibrosis of the lungs in patients with idiopathic pulmonary fibrosis.
How a Medical Algorithm Could Improve Diagnosis of Acute Exacerbations of IPF
We explore a proposed medical algorithm for diagnosing acute exacerbations of IPF and discuss the use of medical algorithms in general.
IPF Features
The Potential Roles of Extracellular Vesicles in AATD and IPF
Extracellular vesicles (EVs) have been implicated in the pathogenesis of a variety of chronic respiratory diseases, including alpha-1 antitrypsin deficiency (AATD) and idiopathic pulmonary fibrosis (IPF). Their role in disease progression makes them an interesting target for diagnostic and therapeutic interventions. The multiple potential functions of EVs in these diseases are discussed by Purghè et…
Understanding the Pathological Formation of Extracellular Matrix in IPF
We know that pathological extracellular matrix (ECM) changes occur in idiopathic pulmonary fibrosis. What drives that, and what can we do about it?
The Link Between Air Pollution and Acute Exacerbations of IPF
Researchers uncover more evidence regarding the detrimental effects of air pollution on acute exacerbations of idiopathic pulmonary fibrosis.
How Our Understanding of IPF Has Evolved in the Last Few Decades
We explore how our understanding of the pathophysiology and treatment of idiopathic pulmonary fibrosis has changed in recent decades.
Rare Care Podcast
Diagnosing and Treating IPF: Insights From Noah Greenspan, DPT, founder of New York City’s Pulmonary Wellness & Rehabilitation Center.
IPF Meeting Coverage
- Loading...
Loading...
Loading... 
Loading...